Cited by 39Retinal Development and DisordersGenetic and Kidney Cyst DiseasesRetinal Diseases and Treatments

Syndromic retinitis pigmentosa.

Open access
Karuntu, Jessica S., Almushattat, Hind, Nguyen, Xuan-Thanh-An, Plomp, Astrid S., Wanders, Ronald J.A., Hoyng, Carel B., van Schooneveld, Mary J., Schalij-Delfos, Nicoline E. +6 more·2025·Progress in Retinal and Eye Research

Abstract

Retinitis pigmentosa (RP) is a progressive inherited retinal dystrophy, characterized by the degeneration of photoreceptors, presenting as a rod-cone dystrophy. Approximately 20-30% of patients with RP also exhibit extra-ocular manifestations in the context of a syndrome. This manuscript discusses the broad spectrum of syndromes associated with RP, pathogenic mechanisms, clinical manifestations, differential diagnoses, clinical management approaches, and future perspectives. Given the diverse clinical and genetic landscape of syndromic RP, the diagnosis may be challenging. However, an accurate and timely diagnosis is essential for optimal clinical management, prognostication, and potential treatment. Broadly, the syndromes associated with RP can be categorized into ciliopathies, inherited metabolic disorders, mitochondrial disorders, and miscellaneous syndromes. Among the ciliopathies associated with RP, Usher syndrome and Bardet-Biedl syndrome are the most well-known. Less common ciliopathies include Cohen syndrome, Joubert syndrome, cranioectodermal dysplasia, asphyxiating thoracic dystrophy, Mainzer-Saldino syndrome, and RHYNS syndrome. Several inherited metabolic disorders can present with RP, including Zellweger spectrum disorders, adult Refsum disease, α-methylacyl-CoA racemase deficiency, certain mucopolysaccharidoses, ataxia with vitamin E deficiency, abetalipoproteinemia, several neuronal ceroid lipofuscinoses, mevalonic aciduria, PKAN/HARP syndrome, PHARC syndrome, and methylmalonic acidaemia with homocystinuria type cobalamin (cbl) C disease. Due to the mitochondria's essential role in supplying continuous energy to the retina, disruption of mitochondrial function can lead to RP, as seen in Kearns-Sayre syndrome, NARP syndrome, primary coenzyme Q10 deficiency, SSBP1-associated disease, and long chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Lastly, Cockayne syndrome and PERCHING syndrome can present with RP, but they do not fit the abovementioned hierarchy and are thus categorized as miscellaneous. Several first-in-human clinical trials are underway or in preparation for some of these syndromic forms of RP.

Integrity signals

Registry

Crossref · 10.1016/j.preteyeres.2024.101324

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Retinal dystrophy is one of the early clinical features in RDLKD patients and occurs even in those with only mild motor or cognitive impairments.

    “In contrast, retinal dystrophy is one of the early clinical features in RDLKD patients and occurs, as also reported for less severe cases of the Zellweger spectrum (Karuntu et al., 2024), even in those with only mild motor or cognitive impairments (Al Shamsi et al., 2025).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Karuntu, J. S., Almushattat, H., Nguyen, X.-T.-A., Plomp, A. S., Wanders, R. J. A., Hoyng, C. B., van Schooneveld, M. J., Schalij-Delfos, N. E., Brands, M. M., Leroy, B. P., van Karnebeek, C. D. M., Bergen, A. A., van Genderen, M. M., & Boon, C. J. F.
Affiliations
  • Leiden University Medical Center (NL)
  • Amsterdam University Medical Centers (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Radboud University Medical Center (NL)
  • Children's Hospital of Philadelphia (US)
Corresponding author
Boon, Camiel J.F.
Venue
Progress in Retinal and Eye Research
Publisher
Elsevier BV
Published
2025-07
Volume
107
Pages
101324
ISSN
1350-9462 (ISSN-L)
OpenAlex
W4405846976
Cited by
39
References
29
Citations by year
2026: 26 · 2025: 13
FWCI
1.59
Type
journal article
Language
en
Open access
Locations
  • Progress in Retinal and Eye Research (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
inherited retinal disease, photoreceptor degeneration, ciliopathies, Usher syndrome, Bardet-Biedl syndrome, inborn errors of metabolism, mitochondrial disease, Zellweger spectrum disorder, Refsum disease, neuronal ceroid lipofuscinosis, Kearns-Sayre syndrome, NARP syndrome, Cockayne syndrome, differential diagnosis, genetic diagnosis, clinical management
MeSH terms
Ciliopathies, Humans, Retinitis Pigmentosa, Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review